Global Medical REIT Inc (NYSE:GMRE) – B. Riley issued their Q4 2018 earnings per share (EPS) estimates for Global Medical REIT in a research note issued to investors on Thursday. B. Riley analyst B. Maher forecasts that the company will post earnings of $0.23 per share for the quarter. B. Riley has a “Buy” rating on the stock. B. Riley also issued estimates for Global Medical REIT’s Q3 2019 earnings at $0.23 EPS.
A number of other research firms have also recently issued reports on GMRE. Zacks Investment Research cut Global Medical REIT from a “buy” rating to a “hold” rating in a research note on Thursday, February 15th. Cantor Fitzgerald initiated coverage on Global Medical REIT in a research note on Wednesday, March 7th. They set a “buy” rating and a $12.00 target price for the company. Finally, TheStreet cut Global Medical REIT from a “c-” rating to a “d” rating in a research note on Thursday, February 1st. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $10.10.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 10th. Stockholders of record on Thursday, March 22nd will be paid a dividend of $0.20 per share. The ex-dividend date is Wednesday, March 21st. This represents a $0.80 annualized dividend and a dividend yield of 11.30%. Global Medical REIT’s dividend payout ratio is currently -470.56%.
Several institutional investors and hedge funds have recently modified their holdings of GMRE. Pacific Ridge Capital Partners LLC bought a new position in shares of Global Medical REIT during the 4th quarter worth approximately $3,266,000. Goldman Sachs Group Inc. grew its stake in shares of Global Medical REIT by 378.6% during the 4th quarter. Goldman Sachs Group Inc. now owns 384,657 shares of the company’s stock worth $3,154,000 after acquiring an additional 304,286 shares in the last quarter. RMR Advisors LLC grew its stake in shares of Global Medical REIT by 169.0% during the 4th quarter. RMR Advisors LLC now owns 345,330 shares of the company’s stock worth $2,832,000 after acquiring an additional 216,943 shares in the last quarter. Renaissance Technologies LLC bought a new position in shares of Global Medical REIT during the 4th quarter worth approximately $1,755,000. Finally, Deutsche Bank AG grew its stake in shares of Global Medical REIT by 676.9% during the 4th quarter. Deutsche Bank AG now owns 163,447 shares of the company’s stock worth $1,339,000 after acquiring an additional 142,408 shares in the last quarter. 44.55% of the stock is owned by institutional investors.
COPYRIGHT VIOLATION WARNING: “Global Medical REIT Inc Expected to Post Q4 2018 Earnings of $0.23 Per Share (GMRE)” was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this article on another site, it was copied illegally and republished in violation of international trademark & copyright law. The original version of this article can be accessed at https://sportsperspectives.com/2018/03/12/global-medical-reit-inc-expected-to-post-q4-2018-earnings-of-0-23-per-share-gmre.html.
About Global Medical REIT
Global Medical REIT Inc is engaged primarily in the acquisition of licensed, purpose-built healthcare facilities and the leasing of these facilities to clinical operators with market share. The Company’s strategy is to produce increasing, reliable rental revenue by expanding its portfolio, and leasing its healthcare facilities to market operators under long-term triple-net leases.
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.